Skip to content

Prevalence and Predictive Factors of Difficult Biliary Cannulation

Prevalence and Predictive Factors of Difficult Biliary Cannulation: a Multicenter Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06591364
Acronym
PRECABIDO
Enrollment
600
Registered
2024-09-19
Start date
2024-09-20
Completion date
2025-10-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difficult Biliary Cannulation

Keywords

ERCP, Endoscopic retrograde cholangiopancreatography, Difficult biliary cannulation

Brief summary

The main purpose of the study is to evaluate the prevalence of difficult biliary cannulation using endoscopic retrograde cholangiopancreatography (ERCP) according to the criteria defined by the European Society of Gastrointestinal Endoscopy (ESGE) and the American Society for Gastrointestinal Endoscopy (ASGE), as well as the predictive factors for this event in a prospective, multicenter study. Consecutive patients undergoing ERCP will be included in the study We will also assess: Evaluate the failure of biliary cannulation in our setting. Evaluate predictive factors for difficult cannulation and cannulation failure using ESGE criteria. Design an a priori predictive model for difficult cannulation and cannulation failure. Cost study: record of materials used.

Detailed description

All consecutive patients who meet the inclusion criteria and none of the exclusion criteria will be offered participation in the study. They will be informed by one of the investigators from each center and will sign an informed consent form. A data collection sheet will be completed to record demographic data, the indication for the procedure, and technical variables. The procedures will be performed by endoscopists with at least 200 ERCPs and more than 5 years of experience. All patients, except in cases of allergy, will receive 1 suppository of indomethacin or diclofenac before the procedure. In cases of allergy, pre-procedure hydration with Ringer's lactate will be administered if there is no contraindication (consider the protocol proposed by the ESGE: 3 mL/kg/hour during ERCP, 20 mL/kg as a bolus after ERCP, and 3 mL/kg/hour for 8 hours post-ERCP). The use of a pancreatic stent should be considered when indicated. After the procedure, patients will remain hospitalized for at least 24 hours in the hospital. The patient's medical record will be reviewed 7 days after the procedure to check for any adverse effects, and a follow-up phone call will be made to detect any adverse effects. Initially, a pilot study will be conducted with 600 patients, assessing based on the results-that is, the percentage of patients with difficult cannulation and the number of independent variables associated in the multiple logistic regression-the need to include a larger number of patients. For each variable included in the multiple logistic regression analysis, 8 to 10 cases of patients with difficult cannulation would be required.

Interventions

None listed

Sponsors

University of La Laguna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 years * Signed informed consent * Patients indicated for ERCP

Exclusion criteria

* INR \> 1.5 * Platelets \< 50,000/mm³ * Patients with a prior endoscopic sphincterotomy * Papilla of Vater not accessible via duodenoscope (gastric or duodenal stenosis due to neoplasm) or gastric surgery (Billroth II, Roux-en-Y) * Known pancreas divisum * Indication due to pancreatic duct pathology

Design outcomes

Primary

MeasureTime frameDescription
Difficult biliary cannulation1 year(\> 5 minutes duration until cannulation, \> 5 cannulation attempts, \> 1 passage of the guidewire into the main pancreatic duct

Secondary

MeasureTime frameDescription
Failure of biliary cannulation1 yearNot possibility of biliary cannulation during the procedure
Predictive factors for difficult cannulation and cannulation failure1 yearFactors independently associated with difficult cannulation and cannulation failure
Designing an a priori predictive model for difficult cannulation and cannulation failure1 yearConsidering the factors independently associated with difficult cannulation and cannulation failure
To carry out a cost study1 yearconsidering direct costs of the procedure

Contacts

Primary ContactAntonio Z Gimeno García, MD, PhD
agimenog@ull.edu.es34922678554

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026